Gaia Bio

Genetically Modified Bacteria

Industrial Technologies
Active
Seed Caesarea Founded 2021
Total raised
Last: SAFE 2025-09
Stage
Seed
Founded
2021
Headcount
7
HQ
Caesarea
Sector
Industrial Technologies

About

Gaia Bio is focused on using a new gene editing technology and proprietary methodology to drastically increase the yields of precision fermentation processes and the effectiveness of bacterial bioremediation and biomining processes.

The company’s innovative approach enables it to engineer a wide array of environmental/wild-type bacteria, as opposed to other companies that can effectively engineer only a limited set of lab-type bacteria. Gaia Bio’s approach is critical for building successful bioleaching and biomining applications, as most require the target bacteria to thrive in acidic environments, which is very hard to achieve with lab-type bacteria.

Gaia Bio’s method can provide up to a fivefold increase in yield of bacteria-based products by finding the best-equipped host (bacteria) for the production of a specific biological product.

Funding history · 3 rounds · — total

2025-09
SAFE Undisclosed
2024-10
SAFE Undisclosed
2022-06
Undisclosed Undisclosed

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was Gaia Bio founded?
Gaia Bio was founded in December 2021.
What is Gaia Bio's primary focus?
Gaia Bio focuses on using new gene editing technology and proprietary methodology to increase yields in precision fermentation processes and enhance bacterial bioremediation and biomining processes.
Where is Gaia Bio headquartered?
Gaia Bio is headquartered in Caesarea, Israel, with an additional office in Herzliya, Israel.
How many employees does Gaia Bio currently have?
Gaia Bio currently has 7 employees.
What type of bacteria can Gaia Bio engineer?
Gaia Bio can engineer a wide array of environmental/wild-type bacteria, which is critical for applications requiring bacteria to thrive in acidic environments.
What is the potential yield increase offered by Gaia Bio's method?
Gaia Bio's method can provide up to a fivefold increase in the yield of bacteria-based products.
Which investor participated in Gaia Bio's undisclosed funding round in June 2022?
VentureIsrael participated in Gaia Bio's undisclosed funding round in June 2022.
When did Gaia Bio secure its most recent SAFE funding round?
Gaia Bio secured its most recent SAFE funding round in September 2025, with participation from VentureIsrael.
What is Gaia Bio's current funding stage?
Gaia Bio is currently in the Seed funding stage.

Sectors & technology

Primary sector
Industrial Technologies
Sub-sectors
Industrial TechnologiesMaterial Innovations & ApplicationsClimate TechClean Industry Tech Sustainable Materials & Circularity
Technologies
BiologicalsGenes
Target customers
Energy, Utilities & Waste ManagementWaste Treatment, Environmental Services & RecyclingAgriculture & FoodLivestockBeefDairyPoultryHealthcare & Life SciencesLife SciencesCosmeticsPharmaceuticalsBiotechnologyDefense, Safety & Security
Business model
B2B

Highlights

Climate TechVerified

Tags

cosmetic-companiesclimate-techalternative-proteinplasticsbiotechnologyrecyclingmaterials